Vivimed Labs Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	10.12	7.08	20.26	37.62	71.84	64.31
Cash & Short-Term Investments	10.12	7.08	20.26	37.62	71.84	64.31
Cash Growth	-	-65.05%	-46.15%	-47.63%	11.71%	-89.98%
Accounts Receivable	893.4	741.1	828.2	741.56	873.64	1,075
Other Receivables	-	-	-	-	-	28.73
Receivables	1,392	1,210	1,242	1,140	1,303	1,303
Inventory	526.97	587.55	640.62	797.6	2,408	2,557
Prepaid Expenses	-	-	-	-	158.67	155.59
Other Current Assets	1,476	1,471	1,523	1,415	1,131	1,207
Total Current Assets	3,406	3,276	3,426	3,390	5,073	5,287
Property, Plant & Equipment	2,657	2,715	2,835	2,988	4,026	4,083
Long-Term Investments	1,685	1,685	1,685	1,988	1,988	1,988
Goodwill	-	169.14	169.14	169.14	169.14	169.14
Other Intangible Assets	1,479	1,364	1,382	1,407	1,404	1,366
Long-Term Deferred Tax Assets	-	-	4.35	-	-	-
Other Long-Term Assets	12.96	-	8.21	7.61	0.03	0.03
Total Assets	9,240	9,208	9,509	9,951	12,660	12,893
Accounts Payable	461.79	394.25	440.69	552.3	418.94	342.52
Accrued Expenses	110.54	313.51	339.27	337.13	125.24	202.61
Short-Term Debt	-	3,127	3,134	2,249	2,176	1,952
Current Portion of Long-Term Debt	3,207	-	-	913.71	802.99	725.77
Current Portion of Leases	-	-	9.08	6.11	-	-
Current Income Taxes Payable	180.03	180.59	180.58	182.91	185.68	187.38
Other Current Liabilities	387.12	66.5	-	-0.01	25.17	-
Total Current Liabilities	4,346	4,082	4,103	4,241	3,734	3,411
Long-Term Debt	633.93	636.15	635.65	623.19	609.93	577.93
Long-Term Leases	-	-	9.5	18.58	-	-
Long-Term Unearned Revenue	-	-	-	-	-	0.37
Pension & Post-Retirement Benefits	49.48	44.85	49	43.81	79.97	63.13
Long-Term Deferred Tax Liabilities	90.33	86.2	90.33	95.15	116.81	85.95
Other Long-Term Liabilities	4,600	4,711	4,676	4,535	4,477	4,439
Total Liabilities	9,720	9,560	9,564	9,556	9,017	8,578
Common Stock	165.83	165.83	165.83	165.83	165.83	165.83
Additional Paid-In Capital	-	2,314	2,314	2,314	-	2,314
Retained Earnings	-	-3,081	-2,767	-2,318	-	1,657
Comprehensive Income & Other	-645.46	250.17	232.27	232.27	3,477	179.5
Total Common Equity	-479.63	-351.69	-54.61	394.22	3,643	4,316
Shareholders' Equity	-479.63	-351.69	-54.61	394.22	3,643	4,316
Total Liabilities & Equity	9,240	9,208	9,509	9,951	12,660	12,893
Total Debt	3,840	3,763	3,788	3,810	3,589	3,256
Net Cash (Debt)	-3,830	-3,756	-3,768	-3,773	-3,517	-3,192
Net Cash Per Share	-46.14	-45.30	-45.44	-45.50	-42.42	-38.50
Filing Date Shares Outstanding	82.97	82.91	82.91	82.91	82.91	82.91
Total Common Shares Outstanding	82.97	82.91	82.91	82.91	82.91	82.91
Working Capital	-940.21	-806.44	-677.42	-851	1,339	1,876
Book Value Per Share	-5.78	-4.24	-0.66	4.75	43.94	52.05
Tangible Book Value	-1,959	-1,884	-1,605	-1,182	2,070	2,780
Tangible Book Value Per Share	-23.61	-22.73	-19.36	-14.26	24.96	33.53
Land	-	1,099	1,099	1,099	1,554	1,554
Buildings	-	1,218	1,205	1,205	1,346	1,346
Machinery	-	3,367	3,294	3,278	3,338	3,041
Construction In Progress	-	171.13	206.51	206.65	400.31	601.23
Leasehold Improvements	-	8.75	8.75	8.75	8.8	2.03

Source: S&P Global Market Intelligence. Standard template. Financial Sources.